Respiratory News and Research

RSS

Scientists decode key molecular gateway for toxin that causes botulism

U.S. and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream.

12 Oct 2013

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi announced today that the U.S. Food and Drug Administration approved Nasacort Allergy 24HR nasal spray as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

12 Oct 2013

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

11 Oct 2013

Novel community program to improve the way childhood asthma controlled outside hospital

Indiana University School of Medicine emergency medicine faculty hope to improve the way childhood asthma is medically managed in Marion County through an innovative program that incorporates the skills and flexible schedules of specially trained Indianapolis Emergency Medical Services paramedics.

11 Oct 2013

Scientists develop new method to create stem cells for human liver and pancreas

A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.

11 Oct 2013

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted and filed the company's supplemental Biologics License Application for subcutaneous use of Xolair (omalizumab) in people with Chronic Idiopathic Urticaria who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses.

11 Oct 2013

Maternal fatty acid intake linked to infant wheeze

Japanese researchers have found that high intake of certain fatty acids by pregnant women is associated with a lower risk for wheeze during infancy in their offspring.

10 Oct 2013

Teva Cutting 5,000 Jobs In Global Restructuring

...

10 Oct 2013

Teleflex to showcase products and technologies at ANESTHESIOLOGY 2013 annual meeting

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, is committed to helping clinicians improve patient outcomes and reduce healthcare costs. Teleflex will showcase its broad portfolio of brands, products and technologies at the ANESTHESIOLOGY 2013 annual meeting, October 12-16, in San Francisco, CA.

10 Oct 2013

New MERS coronavirus emerged from bats to humans: Research

The newly emerged Middle East respiratory syndrome coronavirus has circulated in bats for a substantial time, before making the species leap to humans, according to research published in BioMed Central's open access publication Virology Journal.

10 Oct 2013

Researchers receive grant to improve outcomes for preterm infants who struggle to take first breaths

Monash University researchers have received a prestigious National Institutes of Health (NIH) project grant to find ways to improve outcomes for very preterm infants who struggle to take their first breaths.

10 Oct 2013

Asthma infection risk ‘goes beyond the airways’

Researchers from the USA have found that asthma may be associated with an increased risk for infections outside of the respiratory tract.

9 Oct 2013

Study explores impact of altitude and anemia in children with pneumonia

Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 meters or about 6,500 feet).

9 Oct 2013

Study reveals association between sleep-disordered breathing and Alzheimer's disease

Alzheimer's disease affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy.

9 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

ProTip, Strasbourg University Hospitals complete first implantation of artificial larynx in human patient

ProTip SAS, the specialist developer of innovative medical devices for patients suffering from laryngeal malfunction, and Strasbourg University Hospitals today announce that they have successfully completed the first implantation of an artificial larynx in a human patient.

9 Oct 2013

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.

9 Oct 2013

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it is advancing its Development Candidate for ALN-AS1, an RNAi therapeutic targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of hepatic porphyrias including acute intermittent porphyria (AIP).

9 Oct 2013

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.

9 Oct 2013

Hypothyroidism linked to COPD exacerbation risk

Research shows that chronic obstructive pulmonary disease patients with hypothyroidism have an elevated exacerbation frequency but, despite this, experience similar quality of life to patients with normal thyroid function.

8 Oct 2013

Respiratory News and Research

Scientists decode key molecular gateway for toxin that causes botulism

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Novel community program to improve the way childhood asthma controlled outside hospital

Scientists develop new method to create stem cells for human liver and pancreas

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Maternal fatty acid intake linked to infant wheeze

Teva Cutting 5,000 Jobs In Global Restructuring

Teleflex to showcase products and technologies at ANESTHESIOLOGY 2013 annual meeting

New MERS coronavirus emerged from bats to humans: Research

Researchers receive grant to improve outcomes for preterm infants who struggle to take first breaths

Asthma infection risk ‘goes beyond the airways’

Study explores impact of altitude and anemia in children with pneumonia

Study reveals association between sleep-disordered breathing and Alzheimer's disease

FMCNA encourages dialysis patients to get vaccinated against flu

ProTip, Strasbourg University Hospitals complete first implantation of artificial larynx in human patient

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Hypothyroidism linked to COPD exacerbation risk

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News